Collegium Pharmaceutical (COLL) Interest Expenses (2016 - 2025)
Historic Interest Expenses for Collegium Pharmaceutical (COLL) over the last 9 years, with Q3 2025 value amounting to $21.8 million.
- Collegium Pharmaceutical's Interest Expenses rose 1833.75% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.7 million, marking a year-over-year increase of 2134.96%. This contributed to the annual value of $74.0 million for FY2024, which is 1123.72% down from last year.
- Per Collegium Pharmaceutical's latest filing, its Interest Expenses stood at $21.8 million for Q3 2025, which was up 1833.75% from $20.5 million recorded in Q2 2025.
- Collegium Pharmaceutical's 5-year Interest Expenses high stood at $22.7 million for Q4 2024, and its period low was $4.8 million during Q4 2021.
- In the last 5 years, Collegium Pharmaceutical's Interest Expenses had a median value of $19.0 million in 2022 and averaged $16.0 million.
- In the last 5 years, Collegium Pharmaceutical's Interest Expenses crashed by 3851.62% in 2021 and then surged by 33252.05% in 2022.
- Quarter analysis of 5 years shows Collegium Pharmaceutical's Interest Expenses stood at $4.8 million in 2021, then soared by 332.52% to $20.6 million in 2022, then decreased by 6.29% to $19.3 million in 2023, then increased by 17.49% to $22.7 million in 2024, then dropped by 3.92% to $21.8 million in 2025.
- Its Interest Expenses was $21.8 million in Q3 2025, compared to $20.5 million in Q2 2025 and $20.8 million in Q1 2025.